Abstract
This study examines how uncompensated care, provision of low-profit services, and financial stability differed between nonprofit and public hospitals in the United States that were participating in the 340B drug pricing plan compared with nonparticipating hospitals in 2015.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
